Litcius/Paper detail

Erlotinib-Loaded Poly(ε-Caprolactone) Nanocapsules Improve In Vitro Cytotoxicity and Anticlonogenic Effects on Human A549 Lung Cancer Cells

Franciele Aline Bruinsmann, Julieti H. Buss, Gabriele Dadalt Souto, Eduarda Schultze, Aline de Cristo Soares Alves, Fabiana K. Seixas, Tiago Collares, Adriana Raffin Pohlmann, Sı́lvia Stanisçuaski Guterres

2020AAPS PharmSciTech24 citationsDOI

Topics & Concepts

CytotoxicityNanocapsulesErlotinibA549 cellChemistryLung cancerNanocarriersPharmacologyIn vitroMTT assayApoptosisCancer cellCancer researchDrugCancerMaterials scienceMedicineNanotechnologyEpidermal growth factor receptorNanoparticleBiochemistryOncologyInternal medicineReceptorNanoparticle-Based Drug DeliveryPeptidase Inhibition and AnalysisLung Cancer Research Studies
Erlotinib-Loaded Poly(ε-Caprolactone) Nanocapsules Improve In Vitro Cytotoxicity and Anticlonogenic Effects on Human A549 Lung Cancer Cells | Litcius